Neurodegenerative disorders driven by pathological tau proteins including Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD), Frontotemporal Dementia (FTD), and Pick’s disease (PiD) represent some of the most daunting challenges in modern medicine. For decades, the biomedical research ecosystem has made painstaking progress through hard-won, incremental laboratory discoveries. Yet, as datasets explode in scale, complexity, and heterogeneity, traditional research approaches face a bottleneck: human bandwidth alone can no longer connect all the dots across massive multi-omic, clinical, imaging, and biochemical data.

We are entering a transformative era where Artificial Intelligence (AI) and machine learning (ML) are shifting from novel computational tools to core drivers of biological discovery. Realizing the full potential of AI requires more than just applying algorithms to isolated datasets. It demands a foundational shift in how scientific data is generated, structured, shared, and analyzed.

The Rainwater Charitable Foundation (RCF) and its Tau Consortium are leading this charge with the launch of the Learning Research Network (LRN). The LRN is a groundbreaking initiative designed to catalyze an interoperable, AI-ready ecosystem for primary tauopathies. By coupling cutting-edge technology with radical cross-institutional collaboration, RCF is charting a new course for philanthropic medical research.

The Vision Behind the Learning Research Network

Traditionally, medical research has operated in isolated silos. Individual laboratories generate proprietary datasets, publish static findings in academic journals, and archive raw data in disparate repositories that are often difficult for outside researchers to access or reuse. In an AI-dominated scientific landscape, this model is obsolete. ML models require vast quantities of high-quality, standardized, and machine-readable data to detect subtle biological signals, predict disease progression, and identify viable drug targets.

The LRN was conceived to solve this systemic challenge. Rather than building a single monolithic database or locked software application, RCF is constructing a dynamic, interconnected ecosystem of interoperable scientific resources.

The LRN focuses on three core pillars:

  1. AI-Ready Data: Generating FAIR (Findable, Accessible, Interoperable, and Reusable) datasets built from the ground up for scientific reuse. This includes rigorous curation, rich metadata, standardized ontologies, and benchmark datasets that allow AI algorithms to operate accurately across diverse laboratory settings.
  2. AI-Enabled Collaboration and Workflows: Creating shared digital environments where data, analytical pipelines, workflows, and scientific knowledge converge. This encompasses reusable AI agents, automated analysis workflows, robust APIs, and interactive platforms that connect researchers across the globe in real time.
  3. Strengthening the Neurodegenerative Research Field: Investing in persistent, open infrastructure that extends far beyond individual grant cycles. Key goals include building domain-specific knowledge graphs, foundation models, federated data-sharing frameworks, and semi-autonomous research workflows that raise the baseline capabilities of the entire scientific community.

Why Radical Collaboration is Integral to AI-Led Tau Research

A common misconception about AI in medicine is that powerful algorithms alone can solve biological problems. In reality, an AI model is only as good as the underlying data and domain expertise shaping its training and validation. In neurodegenerative disease research, where biological mechanisms are exceptionally complex and human brain tissue samples are precious, uncoordinated data collection leads to noisy, unreplicable models.

This is why cooperative networks like RCF’s Tau Consortium are uniquely positioned to spearhead AI integration. Established by RCF, the Tau Consortium brings together world-class clinicians, neuropathologists, structural biologists, and pharmacologists who operate under a culture of open communication and shared goals.

By integrating AI into this existing collaborative culture through the LRN, RCF is amplifying the impact of every investigator involved:

  • Bridging Data and Bench Science: Data scientists and ML engineers cannot work in a vacuum. They need direct feedback loops with bench scientists to validate hypotheses in cellular and animal models. Conversely, wet-lab researchers need seamless computational pipelines to make sense of multi-omic screening data.
  • Harmonizing Global Data Resources: Primary tauopathies are rare diseases compared to late-onset Alzheimer’s disease. No single institution possesses enough patient samples or longitudinal data to train robust, disease-specific foundation models on its own. Collective pooling and harmonization of data across teams are essential to achieve statistical power.
  • Accelerating the Translational Pipeline: RCF’s five-year strategic targets are explicitly translational focused on identifying validated therapeutic targets, liquid biomarkers, 4R tau PET imaging ligands, and moving programs into IND-enabling studies. Interoperable AI workflows allow teams to rapidly test thousands of target hypotheses computationally, prioritizing only the most promising candidates for expensive, time-consuming laboratory and clinical validation.

Leading by Example: RCF’s Strategic Philanthropic Leadership

The RCF has long acted as not merely a grant-making organization, but as an active manager and orchestrator of scientific progress. RCF recognizes that driving breakthroughs in rare and complex neurodegenerative diseases requires catalytic capital spent strategically where traditional government and venture funding falls short.

By investing heavily in the infrastructure of the LRN, RCF is redefining the role of disease philanthropies in the 21st century. RCF is proving that funding data standards, workflow tools, and open knowledge graphs yields exponentially higher returns than funding isolated projects in isolation. When one team builds an AI-ready workflow or benchmark dataset under the LRN, every other tau researcher gains access to tools that accelerate their own discoveries.

Furthermore, RCF’s emphasis on persistent infrastructure ensures that scientific utility remains long after an individual grant period ends. Tools, software, and models created within the LRN are required to be made available for broader scientific reuse, multiplying the long-term ROI of every dollar invested.

Announcement: The New LRN Funding Opportunity

To bring this vision to life, the Rainwater Charitable Foundation has launched a major new open funding call under the Tau Consortium – Learning Research Network.

RCF is actively seeking innovative, high-impact proposals from interdisciplinary teams capable of bridging translational tau research with state-of-the-art computational and AI strategies.

Key Grant Highlights & Parameters:

  • Funding Level: Up to $250,000 per participating lab/technical team, with a maximum total project budget of $1,000,000 for collaborative projects spanning up to four participating teams over a 12-month period.
  • Global Open Eligibility: This program is open to everyone. Applicants do not need to be current Tau Consortium investigators. RCF explicitly invites data scientists, software engineers, computational biologists, technical leaders, and academic or commercial research units from eligible organizations worldwide.
  • Focus Areas: Projects must address primary tauopathies (e.g., PSP, CBD, FTD, PiD) while advancing one or more LRN priorities: creating AI-ready FAIR datasets, building reusable AI workflows/agents, or establishing field-strengthening infrastructure (e.g., foundation models, knowledge graphs).
  • Selection Philosophy: The strongest proposals will combine rigorous biological significance such as advancing disease mechanism understanding, target discovery, biomarker identification, or patient stratification with a technically sound, scalable AI and collaborative delivery model.

Key Deadlines & Timeline:

  • Letter of Intent (LOI) Submission Window: September 21, 2026 – October 30, 2026
  • Full Application Invitations: Issued by December 11, 2026
  • Full Applications Due: February 12, 2027
  • Award Announcements: May 2027
  • Project Start Window: July – October 2027

(Note: Indirect costs are not awarded on prime or subawards for this program.)

A Call to Action for the Global Scientific Community

The fight against tau-driven neurodegeneration requires a bold, coordinated effort that unites wet-lab biology, data engineering, and artificial intelligence. Through the Learning Research Network, the Rainwater Charitable Foundation provides both the financial resources and the collaborative framework to make this unified vision a reality.

Whether you are a veteran tau researcher looking to scale your data analysis, a data scientist eager to apply machine learning to meaningful biomedical challenges, or an engineer building next-generation workflow automation, the LRN provides an unprecedented platform to make a lasting impact.

We invite researchers, computational experts, and innovators across academic, clinical, and industrial sectors to review the program guidelines, connect with potential collaborators, and submit a Letter of Intent before the October 30, 2026 deadline.

For complete application guidelines, FAQ, and to submit your LOI, visit the RCF Learning Research Network Program Page.